ACADIA Pharmaceuticals Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:ACAD) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 1.13 B1.23 B1.33 B1.56 B1.61 B Total liabilities 367.13 M403.17 M413.5 M336.81 M357.16 M Total equity 765.24 M822.38 M917.27 M1.23 B1.25 B Total liabilities & shareholders' equities 1.13 B1.23 B1.33 B1.56 B1.61 B Total debt ————— Net debt —————

News

Verastem (VSTM) Surges 6.3%: Is This an Indication of Further Gains?

RPRX or ACAD: Which Is the Better Value Stock Right Now?

About That 'Robust' Earnings Growth

Acadia Pharmaceuticals: Steady Commercial Progress, Remlifanserin Data In Focus

ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome

Strength Seen in Acadia (ACAD): Can Its 6.8% Jump Turn into More Strength?

Stock Indexes Finish Lower as Chipmakers Sell Off

The Surprising Reversal That Drove Acadia Pharma Closer To A Breakout

Acadia (ACAD) Down 3.7% Since Last Earnings Report: Can It Rebound?

Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh

MYGN Cancer Care Strategy: What's Driving 2026 Growth Plans

ACADIA Pharmaceuticals Inc. (ACAD) Presents at Bank of America Global Healthcare Conference 2026 Transcript